Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Ageing, loneliness, and the geographic distribution of New Zealand's interRAI-HC cohort.

Beere P, Keeling S, Jamieson H.

Soc Sci Med. 2018 Aug 11. pii: S0277-9536(18)30426-X. doi: 10.1016/j.socscimed.2018.08.002. [Epub ahead of print]

PMID:
30146450
2.

Comprehensive clinical assessment of home-based older persons within New Zealand: an epidemiological profile of a national cross-section.

Schluter PJ, Ahuriri-Driscoll A, Anderson TJ, Beere P, Brown J, Dalrymple-Alford J, David T, Davidson A, Gillon DA, Hirdes J, Keeling S, Kingham S, Lacey C, Menclova AK, Millar N, Mor V, Jamieson HA.

Aust N Z J Public Health. 2016 Aug;40(4):349-55. doi: 10.1111/1753-6405.12525. Epub 2016 May 15.

PMID:
27197797
3.

Social and spatial inequalities in Rotaviral enteritis: a case for universally funded vaccination in New Zealand.

Bowie C, Campbell M, Beere P, Kingham S.

N Z Med J. 2016 Mar 11;129(1431):59-66.

PMID:
27005875
4.

Population access to hospital emergency departments and the impacts of health reform in New Zealand.

Brabyn L, Beere P.

Health Informatics J. 2006 Sep;12(3):227-37.

PMID:
17023410
5.

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

Girman CJ, Rhodes T, Mercuri M, Pyörälä K, Kjekshus J, Pedersen TR, Beere PA, Gotto AM, Clearfield M; 4S Group and the AFCAPS/TexCAPS Research Group.

Am J Cardiol. 2004 Jan 15;93(2):136-41.

PMID:
14715336
6.

Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women.

Clearfield M, Downs JR, Weis S, Whitney EJ, Kruyer W, Shapiro DR, Stein EA, Langendorfer A, Beere PA, Gotto AM.

J Womens Health Gend Based Med. 2001 Dec;10(10):971-81.

PMID:
11788107
7.

Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin.

Downs JR, Clearfield M, Tyroler HA, Whitney EJ, Kruyer W, Langendorfer A, Zagrebelsky V, Weis S, Shapiro DR, Beere PA, Gotto AM.

Am J Cardiol. 2001 May 1;87(9):1074-9.

PMID:
11348605
8.

Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

Gotto AM Jr, Whitney E, Stein EA, Shapiro DR, Clearfield M, Weis S, Jou JY, Langendörfer A, Beere PA, Watson DJ, Downs JR, de Cani JS.

Eur Heart J. 2000 Oct;21(19):1627-33.

PMID:
10988016
9.

Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): baseline characteristics and comparison with USA population.

Clearfield M, Whitney EJ, Weis S, Downs JR, Shapiro DR, Stein EA, Watson DJ, Langendörfer A, Beere PA, Stamler J, Gotto AM Jr.

J Cardiovasc Risk. 2000 Apr;7(2):125-33.

PMID:
10879416
10.

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

Gotto AM Jr, Whitney E, Stein EA, Shapiro DR, Clearfield M, Weis S, Jou JY, Langendörfer A, Beere PA, Watson DJ, Downs JR, de Cani JS.

Circulation. 2000 Feb 8;101(5):477-84.

PMID:
10662743
11.

Aerobic exercise training can reverse age-related peripheral circulatory changes in healthy older men.

Beere PA, Russell SD, Morey MC, Kitzman DW, Higginbotham MB.

Circulation. 1999 Sep 7;100(10):1085-94.

PMID:
10477534
12.

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr.

JAMA. 1998 May 27;279(20):1615-22.

PMID:
9613910
14.

Design & rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

Downs JR, Beere PA, Whitney E, Clearfield M, Weis S, Rochen J, Stein EA, Shapiro DR, Langendorfer A, Gotto AM Jr.

Am J Cardiol. 1997 Aug 1;80(3):287-93.

PMID:
9264420
16.
17.

Retarding effect of lowered heart rate on coronary atherosclerosis.

Beere PA, Glagov S, Zarins CK.

Science. 1984 Oct 12;226(4671):180-2.

PMID:
6484569
18.

Parallel growth of rectus sheath grafts and recipient aorta. Critical role of graft tissue preservation.

Bilfinger TV, Beere PE, Sanderson C, Glagov S, Anagnostopoulos CE.

J Thorac Cardiovasc Surg. 1983 Aug;86(2):294-9.

PMID:
6224050
19.

Acute aortic dissection. An historical review.

Sanderson CJ, Cote RJ, Levett JM, Beere P, Anagnostopoulos CE.

J R Coll Surg Edinb. 1982 Jul;27(4):195-9. Review. No abstract available.

PMID:
6752396
20.

Clotted false lumen: reappraisal of indications for medical management of acute aortic dissection.

Sanderson CJ, Rich S, Beere PA, Anagnostopoulos CE, Levett JM, Lawrence JM.

Thorax. 1981 Mar;36(3):194-9.

21.

Retrograde coronary venous perfusion at low pressure.

Toscano MF, Kampman KM, Beere PA, Bates RJ, Demos SS, Anagnostopoulos CE.

Cardiovasc Dis. 1980 Mar;7(1):41-50.

22.

Autologous rectus sheath grafts. V. Growth in aortic grafts.

Anagnostopoulos CE, Beere PA, Athanasuleas CL, Spirtos N, Glagov S, Balderman SC, Collins PA.

J Thorac Cardiovasc Surg. 1979 Nov;78(5):784-91.

PMID:
158682

Supplemental Content

Support Center